https://news.thecrimsonreport.com/story/618002/idiopathic-pulmonary-fibrosis-clinical-trial-pipeline-accelerates-as-80-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight.html 2026-04-28T16:34:37+00:00 daily 1.0 https://news.thecrimsonreport.com/story/618001/phenylketonuria-clinical-trial-pipeline-gains-momentum-20-companies-lead-the-charge-in-pioneering-new-treatments-delveinsight.html 2026-04-28T16:32:29+00:00 daily 1.0 https://news.thecrimsonreport.com/story/617999/acute-respiratory-distress-syndrome-clinical-trial-pipeline-appears-robust-with-50-key-pharma-companies-actively-working-in-the-domain-delveinsight.html 2026-04-28T16:30:40+00:00 daily 1.0 https://news.thecrimsonreport.com/story/617998/sickle-cell-disease-clinical-trial-pipeline-shows-potential-with-active-contributions-from-55-key-companies-delveinsight.html 2026-04-28T16:29:01+00:00 daily 1.0 https://news.thecrimsonreport.com/story/617996/acute-myeloid-leukemia-clinical-trial-pipeline-accelerates-as-100-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight.html 2026-04-28T16:26:59+00:00 daily 1.0 https://news.thecrimsonreport.com/story/617995/nsclc-clinical-trial-pipeline-gains-momentum100-companies-lead-the-charge-in-pioneering-new-treatments-delveinsight.html 2026-04-28T16:25:23+00:00 daily 1.0 https://news.thecrimsonreport.com/story/617994/medullary-thyroid-cancer-pipeline-set-for-strategic-expansion-through-2026-with-10-emerging-therapies-and-robust-innovation-from-bayer-healthcare-and-applied-pharmaceutical-science-delveinsight.html 2026-04-28T16:23:33+00:00 daily 1.0 https://news.thecrimsonreport.com/story/617993/postoperative-pain-pipeline-enters-a-new-era-with-50-therapies-and-40-companies-driving-innovation-in-multimodal-analgesia-and-longacting-pain-relief-delveinsight.html 2026-04-28T16:20:30+00:00 daily 1.0 https://news.thecrimsonreport.com/story/617991/hemophilia-b-pipeline-set-for-transformational-breakthroughs-by-2026-with-20-therapies-and-nextgeneration-gene-editing-advances-led-by-biocad-regeneron-and-be-biopharma-delveinsight.html 2026-04-28T16:18:43+00:00 daily 1.0 https://news.thecrimsonreport.com/story/617990/pancreatic-cancer-pipeline-enters-a-new-era-of-precision-oncology-with-200-therapies-and-170-companies-advancing-nextgeneration-treatments-delveinsight.html 2026-04-28T16:16:55+00:00 daily 1.0